Shen-Ming Huang,Meng-Yao Xiong,Lei Liu,Jianqiang Mu,Ming-Wei Wang,Ying-Li Jia,Kui Cai,Lu Tie,Chao Zhang,Sheng Cao,Xin Wen,Jia-Le Wang,Sheng-Chao Guo,Yu Li,Chang-Xiu Qu,Qing-Tao He,Bo-Yang Cai,Chenyang Xue,Shiyi Gan,Yihe Xie,Xin Cong,Zhao Yang,Wei Kong,Shuo Li,Zijian Li,Peng Xiao,Fan Yang,Xiao Yu,You-Fei Guan,Xiaoyan Zhang,Zhongmin Liu,Bao-Xue Yang,Yan Du,Jin-Peng Sun

Abstract:To accomplish concerted physiological reactions, nature has diversified functions of a single hormone at at least two primary levels: 1) Different receptors recognize the same hormone, and 2) different cellular effectors couple to the same hormone-receptor pair [R.P. Xiao, Sci STKE 2001, re15 (2001); L. Hein, J. D. Altman, B.K. Kobilka, Nature 402, 181-184 (1999); Y. Daaka, L. M. Luttrell, R. J. Lefkowitz, Nature 390, 88-91 (1997)]. Not only these questions lie in the heart of hormone actions and receptor signaling but also dissecting mechanisms underlying these questions could offer therapeutic routes for refractory diseases, such as kidney injury (KI) or X-linked nephrogenic diabetes insipidus (NDI). Here, we identified that Gs-biased signaling, but not Gi activation downstream of EP4, showed beneficial effects for both KI and NDI treatments. Notably, by solving Cryo-electron microscope (cryo-EM) structures of EP3-Gi, EP4-Gs, and EP4-Gi in complex with endogenous prostaglandin E2 (PGE2)or two synthetic agonists and comparing with PGE2-EP2-Gs structures, we found that unique primary sequences of prostaglandin E2 receptor (EP) receptors and distinct conformational states of the EP4 ligand pocket govern the Gs/Gi transducer coupling selectivity through different structural propagation paths, especially via TM6 and TM7, to generate selective cytoplasmic structural features. In particular, the orientation of the PGE2 ω-chain and two distinct pockets encompassing agonist L902688 of EP4 were differentiated by their Gs/Gi coupling ability. Further, we identified common and distinct features of cytoplasmic side of EP receptors for Gs/Gi coupling and provide a structural basis for selective and biased agonist design of EP4 with therapeutic potential.

Total synthesis and structure–activity relationship studies of a series of selective G protein inhibitors

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-based Hydroxamic Acids As PI3K and HDAC Dual Targeting Inhibitors

Stabilization of interdomain closure by a G protein inhibitor

Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

The G protein inhibitor YM-254890 is an allosteric glue

Design, synthesis, and analysis of macrobicyclic peptides for targeting the Gαi protein

Structure-Based Design and Synthesis of Novel Type Quinoline As Secretory Pla(2) Inhibitors

Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives As Human G Protein-Coupled Receptor-35 (hgpr35) Agonists and a Consequent New Design Principle.

Structure−Activity Relationship Studies and in Vivo Activity of Guanidine-Based Sphingosine Kinase Inhibitors: Discovery of SphK1- and SphK2-Selective Inhibitors

Syntheses and evaluation of daphnetin derivatives as novel G protein-coupled receptor inhibitors and activators

Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists

Discovery of GPCR ligands for probing signal transduction pathways

Structure-activity relationship studies of tetrahydroquinolone derivatives as GPR41 modulators

Molecular Mechanism of Action of GPR91 Agonists and Antagonists: Insights from Molecular Dynamics Simulation

Structure and dynamics determine G protein coupling specificity at a class A GPCR

In Vitro Module Editing Of NRPS Enables Production Of Highly Potent Gq‐Signaling Inhibitor FR900359 Derived From Unculturable Plant Symbiont

Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139

Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target